{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:19:29Z","timestamp":1784132369022,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:00:00Z","timestamp":1743120000000},"content-version":"am","delay-in-days":361,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clml.2023.12.017","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:15:23Z","timestamp":1704327323000},"page":"e174-e180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Racial Disparities in Mycosis Fungoides\/S\u00e9zary Syndrome\u2013A Single-Center Observational Study of 292 Patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Ashley R.","family":"Gandham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1206-1057","authenticated-orcid":false,"given":"Shamir","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0747-2479","authenticated-orcid":false,"given":"Stephen W.","family":"Dusza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Kupper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia. L.","family":"Myskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2023.12.017_bib0001","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jamaoncol.2022.3236","article-title":"Incidence trends of primary cutaneous T-cell lymphoma in the US from 2000 to 2018: a SEER population data analysis","volume":"8","author":"Cai","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2023.12.017_bib0002","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.clml.2023.12.017_bib0003","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma","volume":"12","author":"Wilson","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.12.017_bib0004","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.12.017_bib0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clml.2013.12.018","article-title":"Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008","volume":"14","author":"Nath","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2023.12.017_bib0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2008.09.063","article-title":"Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides","volume":"60","author":"Sun","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0007","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3109\/10428194.2012.729831","article-title":"Incidence and survival patterns of cutaneous T-cell lymphomas in the United States","volume":"54","author":"Imam","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.12.017_bib0008","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<208::AID-CNCR28>3.0.CO;2-2","article-title":"The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States","volume":"85","author":"Weinstock","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2023.12.017_bib0009","doi-asserted-by":"crossref","first-page":"AB182","DOI":"10.1016\/j.jaad.2016.02.717","article-title":"Racial differences in survival of patients with Sezary syndrome in the United States: a population-based study of 204 cases","volume":"74","author":"Jang","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","article-title":"Racial disparity in mycosis fungoides: an analysis of 4495 cases from the US National Cancer Database","volume":"77","author":"Su","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0011","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/jamadermatol.2022.3601","article-title":"Clinical presentation and outcome differences between black patients and patients of other races and ethnicities with mycosis fungoides and S\u00e9zary syndrome","volume":"158","author":"Allen","year":"2022","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.clml.2023.12.017_bib0012","first-page":"633","article-title":"Racial disparities in the clinical presentation and prognosis of patients with mycosis fungoides","volume":"111","author":"Huang","year":"2019","journal-title":"J Natl Med Assoc"},{"key":"10.1016\/j.clml.2023.12.017_bib0013","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jaad.2022.06.1193","article-title":"Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color-part I: genetic, biologic, and structural differences in skin of color","volume":"87","author":"Brown-Korsah","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0014","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jaad.2019.08.073","article-title":"Outcomes and prognostic factors in African American and black patients with mycosis fungoides\/S\u00e9zary syndrome: retrospective analysis of 157 patients from a referral cancer center","volume":"83","author":"Geller","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0015","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2105\/AJPH.89.8.1240","article-title":"Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality","volume":"89","author":"Weinstock","year":"1999","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clml.2023.12.017_bib0016","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0017","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2014.10.019","article-title":"Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sezary syndrome in the southeastern United States: a single-institution cohort","volume":"72","author":"Desai","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0018","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/bjd.21034","article-title":"Demographic factors and disparate outcomes in mycosis fungoides: retrospective analysis of a racially diverse 440-patient cohort from Detroit, Michigan, USA","volume":"187","author":"Buechler","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0019","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1080\/10428194.2022.2067999","article-title":"African American and Caucasian patients with S\u00e9zary syndrome have no differences in outcomes at an ethnically diverse urban medical center","volume":"63","author":"Martini","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.12.017_bib0020","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaad.2021.12.016","article-title":"Contribution of socioeconomic risk factors within a diverse mycosis fungoides cohort from Detroit, Michigan","volume":"87","author":"Buechler","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0021","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.12.017_bib0022","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.12.017_bib0023","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2023.12.017_bib0024","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/ijd.16374","article-title":"Cutaneous lymphomas in African American\/Black patients: pitfalls and presentations","volume":"62","author":"Flaum-Dunoyer","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007425","article-title":"Race and socioeconomic status independently affect risk of major amputation in peripheral artery disease","volume":"7","author":"Arya","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.clml.2023.12.017_bib0026","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ajog.2017.10.010","article-title":"Trends in pelvic inflammatory disease emergency department visits, United States, 2006-2013","volume":"218","author":"Kreisel","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clml.2023.12.017_bib0027","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaad.2022.10.029","article-title":"Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients","volume":"88","author":"Hooper","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0028","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1007\/s00520-021-06241-6","article-title":"The impact of gender, age, race\/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas","volume":"29","author":"Martinez","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clml.2023.12.017_bib0029","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00403-022-02360-0","article-title":"Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study","volume":"315","author":"Nguyen","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clml.2023.12.017_bib0030","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.jaad.2021.06.006","article-title":"Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: a cross-sectional analysis of the 2012-2017 National Inpatient Sample","volume":"86","author":"Choi","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0031","doi-asserted-by":"crossref","first-page":"232","DOI":"10.12788\/cutis.0247","article-title":"Mycosis fungoides in Black patients: time for a better look","volume":"107","author":"Myskowski","year":"2021","journal-title":"Cutis"},{"key":"10.1016\/j.clml.2023.12.017_bib0032","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaad.2022.03.067","article-title":"Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: differences in clinical presentation and disparities in cutaneous disorders in skin of color","volume":"87","author":"McKenzie","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clml.2023.12.017_bib0033","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3390\/cancers12082007","article-title":"Hypopigmented mycosis fungoides: loss of pigmentation reflects antitumor immune response in young patients","volume":"12","author":"Mart\u00ednez Villarreal","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clml.2023.12.017_bib0034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clicom.2023.07.004","article-title":"Immunopathogenesis of cutaneous T-cell lymphoma in skin of color patients part 1: mycosis fungoides","volume":"4","author":"Desse","year":"2023","journal-title":"Clin Immunol Commun"},{"key":"10.1016\/j.clml.2023.12.017_bib0035","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.anai.2018.11.015","article-title":"Racial differences in atopic dermatitis","volume":"122","author":"Brunner","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clml.2023.12.017_bib0036","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2018.08.024","article-title":"Atopic dermatitis in African American patients is T(H)2\/T(H)22-skewed with T(H)1\/T(H)17 attenuation","volume":"122","author":"Sanyal","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clml.2023.12.017_bib0037","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1080\/10428194.2021.1888376","article-title":"Clinical characteristics and outcomes of black patients with mycosis fungoides and S\u00e9zary syndrome: a subgroup analysis of the phase III MAVORIC trial","volume":"62","author":"Johnson","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2023.12.017_bib0038","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0b013e31825494d3","article-title":"Treatment of mycosis fungoides with total skin electron beam: response and relapse by ethnicity and sex","volume":"36","author":"Hinds","year":"2013","journal-title":"Am J Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023022176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265023022176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T02:14:04Z","timestamp":1712542444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265023022176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2152265023022176"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2023.12.017","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial Disparities in Mycosis Fungoides\/S\u00e9zary Syndrome\u2013A Single-Center Observational Study of 292 Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2023.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}